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Defective permeability barrier is an important feature of many skin diseases and causes mortality in premature infants. To investigate the
control of barrier formation, we characterized the epidermally expressed Grainyhead-like epithelial transactivator (Get-1)/Grhl3, a conserved
mammalian homologue of Grainyhead, which plays important roles in cuticle development in Drosophila. Get-1 interacts with the LIM-only
protein LMO4, which is co-expressed in the developing mammalian epidermis. The epidermis of Get-1−/− mice showed a severe barrier function
defect associated with impaired differentiation of the epidermis, including defects of the stratum corneum, extracellular lipid composition and cell
adhesion in the granular layer. The Get-1 mutation affects multiple genes linked to terminal differentiation and barrier function, including most
genes of the epidermal differentiation complex. Get-1 therefore directly or indirectly regulates a broad array of epidermal differentiation genes
encoding structural proteins, lipid metabolizing enzymes and cell adhesion molecules. Although deletion of the LMO4 gene had no overt
consequences for epidermal development, the epidermal terminal differentiation defect in mice deleted for both Get-1 and LMO4 is much more
severe than in Get-1−/− mice with striking impairment of stratum corneum formation. These findings indicate that the Get-1 and LMO4 genes
interact functionally to regulate epidermal terminal differentiation.
© 2006 Elsevier Inc. All rights reserved.Keywords: Get-1; LMO4; Epidermal differentiation; Epidermal differentiation complex; Epidermal barrier; GrainyheadIntroduction
The stratified mammalian epidermis develops from somatic
ectoderm late in embryogenesis. As keratinocytes move from
the proliferating basal cell layer towards the surface, they
undergo a series of differentiation steps to form morphologi-
cally distinct suprabasal layers: the spinous, granular and
cornified layers. One of the key roles of this process is to form
an effective permeability barrier, which depends on several
components of the cornified and granular layer (Candi et al.,⁎ Corresponding author. Fax: +1 949 824 2200.
E-mail address: bogi@uci.edu (B. Andersen).
0012-1606/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.07.0152005). As a consequence of defective epidermal differentiation,
premature infants suffer both from increased transepidermal
water loss and percutaneous absorption of chemicals, as well as
a fragile skin (Shwayder and Akland, 2005). Barrier function is
also defective in several hereditary and acquired inflammatory
skin diseases (Nickoloff, 2006).
The cornified envelope is composed of a complex of cross-
linked structural proteins that form a rigid structure in the dead
cells of the cornified layer. These cells are surrounded by lipid
lamellae composed of a mixture of lipids, some of which are
cross-linked to the cornified envelope. Cross-linking enzymes
such as transglutaminases and metabolic enzymes expressed in
the granular layer are responsible for protein cross-linking and
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granular layer, including desmosomes and tight junction
proteins, are critical for an effective barrier (Segre, 2003).
Very little is known about the coordinated regulation of
gene expression that is required for formation of the epidermal
barrier (Segre, 2003). In an effort to understand transcriptional
regulation of epidermal differentiation, we previously identi-
fied two interacting proteins in the developing epidermis: the
LIM-only factor LMO4 and Grainyhead-like epithelial trans-
activator (Get-1; also referred to as Grainyhead-like transcrip-
tion factor 3/Grhl3) (Kudryavtseva et al., 2003; Sugihara et al.,
1998). LMO4 is a transcriptional co-regulator thought to
coordinate larger transcriptional complexes by interacting with
DNA-binding proteins (Sugihara et al., 1998). Get-1 is a
conserved mammalian homologue of the DNA-binding protein
Grainyhead (Kudryavtseva et al., 2003; Ting et al., 2003b),
which plays an important role in Drosophila cuticle formation
(Bray and Kafatos, 1991; Mace et al., 2005). The conserved
expression of Drosophila Grainyhead and Get-1 suggested a
role for Get-1 in mammalian epidermis formation (Kudryavt-
seva et al., 2003).
During embryonic development of the epidermis, Get-1 and
LMO4 are co-expressed in the epidermal keratinocytes and
interact in vitro (Kudryavtseva et al., 2003), suggesting that
both Get-1 and LMO4 might be important for epidermal
differentiation. To test this prediction, we studied epidermal
development in mice deleted for Get-1 and LMO4. Get-1
deletion disrupted terminal differentiation and barrier function
of the epidermis. Ting et al. (2005) suggested that down-
regulation of transglutaminase 1 (Tgm1), a key cross-linking
enzyme in epidermal differentiation, is responsible for the
epidermal barrier defect and impaired wound healing in Get-
1−/− mice. In contrast, we found that Get-1 regulates multiple
components of the epidermal barrier in addition to Tgm1,
including structural and cell adhesion genes, as well as the
lipid component. Furthermore, knockout of LMO4 enhanced
the terminal differentiation defect in Get-1−/− mice, indicating
functional interactions between Get-1 and LMO4 in the
regulation of the terminal differentiation program in the
epidermis.
Materials and methods
Generation of Get-1−/− and LMO4−/− mice
A gene-targeting vector was constructed using PCR from 129/SvJae
mouse genomic DNA. A 5′ homology arm (3602 bp), a 3′ homology arm
(2891 bp) and a loxP arm (2257 bp) were isolated and cloned into the pFOz
(3L) vector. The linearized targeting vector was introduced into ES cells by
electroporation. Electroporated C57Bl/6J ES cells were grown on selection
medium containing G418 (GIBCO BRL). G418-resistant ES cells were
isolated and screened by Southern blotting of KpnI-digested genomic DNA
with 5′ and 3′ probes, and positive ES cell clones were used to generate the
Get-1 chimeric mice. The chimeric mice were intercrossed with C57Bl/6J
mice to obtain Get-1 floxed mice. The Get-1 heterozygous knockout mice
were obtained by crossing the floxed mice with a Cre-deletor (Schwenk et al.,
1995) to remove the DNA fragment from exon 4 to exon 7. The generation of
LMO4−/− mice was previously described (Lee et al., 2005). Sequences of
oligonucleotides used for genotyping and RT-PCR of Get-1 mRNA are
provided in Supplementary Table 1.RT-PCR analysis
Semi-quantitative RT-PCR was performed on total RNA prepared from
E18.5 backskin of WT and Get-1−/− embryos using Trizol Reagent
(Invitrogen) and the High Capacity cDNA Archive Kit (Applied Biosystems).
Reactions were sampled after 25, 28 and 30 cycles at different PCR conditions
to monitor product accumulation. Sequence of primers is in Supplementary
Table 1.
Histology, immunohistology and BrdU staining
Backskin was fixed in 10% formalin, paraffin-embedded and 6-μm
sections were stained with hematoxylin and eosin (H&E). For immunohis-
tochemistry, skin tissues were fixed in 6 parts 100% Ethanol, 3 parts water and
1 part Formaldehyde. Antigen-retrieval was performed by heating slides to
95°C for 10 min in 0.01 M citrate buffer (pH 6) in a microwave oven. The
sections were then immunostained by the ABC peroxidase method (vector)
with diaminobenzidine as the enzyme substrate and hematoxylin as a
counterstain. For immunofluorescence, 6-μm-thick fresh frozen sections
were air-dried and then washed with PBS. Later, these sections were soaked
in blocking solution for 30 min, incubated with occludin mAb for 2 h, washed
three times with blocking solution, then incubated with FITC anti-rat IgG pAb
(Oncogene Research Products) and counterstained with DAPI in mounting
media. For BrdU detection, BrdU (0.05 mg/g) was injected intraperitoneally
2 h prior to sacrifice of the pregnant mother. Embryos were fixed in 10%
buffered formalin and paraffin embedded. Slides were pre-treated in 1 M HCl
for 1 h at 37°C prior to adding antibody. The primary antibodies used in
immunostaining were as follows: rabbit anti-mouse MK5 (Covance), mouse
anti-human cytokeratin 10 (DakoCytomation), rabbit anti-mouse filaggrin
(Covance), rabbit anti-mouse loricrin (Covance), mouse anti-mouse occludin
(Zymed), rabbit anti-mouse claudin 1 (Abcam), rabbit anti-mouse claudin 4
(Abcam), rabbit anti-mouse caspase 14 (Abcam), Rabbit anti-mouse involucrin
(Covance) and anti-bromodeoxyuridine (Roche).
In situ hybridization
In situ hybridization studies with 35S-labeled cRNA probes were
performed on frozen sections counterstained with bisbenzamide as described
previously (Andersen et al., 1995).
Epidermal barrier permeability assay
To assess the epidermal permeability barrier, we used the skin permeability
assay described previously (Hardman et al., 1998). After staining, the embryos
were photographed using a Nikon E995 digital camera.
Transmission electron microscopy
Fresh skin was dissected into small pieces and fixed by immersion in 2%
paraformaldehyde and 2.5% glutaraldehyde in 0.1 M PBS (pH 7.4). Tissues
were fixed in room temperature and then washed for four times with PBS.
They were postfixed with 0.2% ruthenium tetroxide (RuO4) and dehydrated
through graded ethanol series and embedded in agar 100 resin. Ultrathin
sections were contrasted with uranyl acetate and lead citrate and examined on
a transmission electron microscope.
Preparation of cornified envelopes (CEs) and sonication experiments
Embryo skin was processed with dispase at 37°C for 30 min and epidermis
was isolated. CEs were prepared by heating epidermis at 95°C for 10 min in
preheated extraction buffer (0.1 M Tris pH 8.5, 2% SDS, 20 mM DTT, 5 mM
EDTA pH 7.5). CEs were collected by centrifugation of 5000×g for 15 min
and stored in 500 μl extraction buffer. For sonication, CEs were diluted in
extraction buffer and the CE suspension was sonicated in Eppendorf tubes on
ice for different time points. CE aliquots were photographed.
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Epidermis was isolated from e18.5 WT, heterozygous and Get-1 knockout
embryos as described above. Lipid analysis from pooled epidermis
preparations was performed as previously described (Law et al., 1995).
Similar results were obtained in four independent experiments.
RNA isolation and microarray experiments
The same region of the mouse backskin was excised from three Get1-1+/+
and three Get1-1−/− mice at e18.5. Microarray experiments were performed as
previously described except we used Affymetrix Murine Genome 430 2.0Fig. 1. Generation and phenotypes of Get-1−/− mice. (A) Strategy for targeted delet
Southern blots are indicated. (B) The first two panels show Southern blot analysis of
with 3′ and 5′ probes. The third panel shows PCR identification of genotypes of mice
panel shows absence of Get-1 mRNA inGet-1−/−mice by RT-PCR. (C) Appearance o
indicate spina bifida. (D) Higher magnification images of spina bifida, curly tail and
open-eye, spina bifida and curly tail phenotypes. Arrowheads point to the eyelid closu
mice. Arrow points to blood in intestine.arrays (45,037 probe sets) and washed according to manufacturer's
recommendations (Affymetrix, Santa Clara, CA) (Lin et al., 2004).
Cyber-T analysis
After excluding absent genes, the raw expression values from replicate
samples were analyzed by the Cyber-T program (Baldi and Long, 2001), which
identifies statistically significant differentially expressed genes. We implemen-
ted the following filtering criterion to exclude absent genes from subsequent
analysis: all three replicate samples of either Get1-1+/+ or Get1-1−/− mice must
have “present” or “marginally present” calls, as determined by MAS 5.0. To
determine the global false positive rate inherent in multiple hypotheses testingion of the Get-1 gene. Exons are represented as boxes. Locations of probes for
KpnI-digested genomic DNA from WT (+/+) and targeted (+/−) embryonic cells
using primers detecting normal (WT) and deleted (MUT) Get-1 loci. The fourth
f Get-1−/−mice at e16.5 and e18.5. Arrowheads indicate exencephaly and arrows
open-eye phenotypes in Get-1−/− mice. (E) Histology of e18.5 embryos shows
re front and arrows point to the cornea. (F) Overview of the intestine of Get-1−/−
Fig. 2. Impaired epithelial differentiation in Get-1−/− epidermis and forestomach. (A–C) Histological analysis of e18.5 backskin from WT (A) and Get-1−/− (B–C)
embryos. Arrowheads in C point to nuclei in the stratum corneum. (D–O) Immunostaining analysis of e18.5 backskin from WT (D, F, H, J, L and N) and Get-1−/− (E,
G, I, K, M and O) embryos. Antibodies to the following keratinocyte differentiation markers were used, K5 (D–E), K10 (F–G), K6 (H–I), involucrin (J–K), loricrin
(L–M) and filaggrin (N–O). (P) BrdU staining of e18.5 backskin from WT (left panel) and Get-1−/− (right panel) embryos. (Q) The ratio of BrdU positive cells in the
basal cell layer of e18.5 backskin with the indicated genotypes. Results represent mean and standard error. The asterisk denotes statistically significant difference
betweenWT/heterozygous andGet 1−/−mice (P<0.02). (S) Histological analysis of forestomach epithelium from e18.5 mice with the indicated genotypes. (T) Higher
magnification of the images shown in S. (U) Filaggrin immunostaining of forestomach epithelium from e18.5 mice with the indicated genotypes. (V) Loricrin
immunostaining of forestomach epithelium from e18.5 mice with the indicated genotypes. Scale bars: A–C, 25 μm; D–S, U and V, 50 μm; T, 12.5 μm. H/E,
hematoxylin/eosin staining; SB, basal layer; SC, cornified layer; SG, granular layer; SS, spinous layer.
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expression (PPDE) was calculated using the P values of log-transformed data.
The PPDE for the selected cut-off P value of 0.0025 is 0.80, which indicates
that the false discovery rate is within 20%. Overrepresented gene ontology
biological process categories and chromosomal band localization for
differentially expressed genes were determined using the DAVID (Database
for Annotation, Visualization and Integrated Discovery) 2.0 program (Dennis
et al., 2003).
Batch extraction and analysis of cis-regulatory regions (BEARR)
BEARR was used to determine the possible Get-1 binding sequence
using position weight matrix score (PWM score ≥6.73) by extracting the
promoter regions (2 kb upstream region of transcription start site) of
significantly altered genes in the microarray (Vega et al., 2004). The PWM
input used for the analysis was from the core Get-1 DNA binding consensus
sequence (AACCGGTT) derived from a previously published CASTing
results (Ting et al., 2005). The sequence and annotation database selected
for BEARR analysis was the Mouse Genome Assembly NCBI Build 33. Of
the 162 unique genes identified by Cyber-T to be downregulated, BEARR
was able to obtain 2 kb upstream sequence for 136 genes, and 35 of these
genes (25.7%) have sites with PWM scores ≥6.73. Of the 69 unique genes
identified by Cyber-T to be upregulated, BEARR was able to obtain 2 kb
upstream sequence for 59 genes, and 12 of these genes (20.3%) have sites
with PWM scores ≥6.73. To estimate the expected number of genes
identified to have upstream sites with PWM scores ≥6.73 by chance (false
positives), we systematically performed PWM analysis on statistically
significant non-regulated genes by Get-1 (P>0.99 from Cyber-T analysis;
246 probe sets, corresponding to 192 unique genes). For these non-regulated
genes, BEARR was able to obtain 2 kb upstream sequence for 173 genes,
and 31 of these genes (17.9%) have sites with PWM scores ≥6.73. In
running the ConSite program (Sandelin et al., 2004), we used 75% as the
cut-off threshold for conservation of Get-1 binding sites and genomic
regions with a sliding window of 50 bp.Fig. 3. Defective epidermal permeability barrier and abnormal epidermal lipid com
staining of mouse embryos of the indicated ages and genotypes. (B) Ultrasound fragi
the indicated genotypes. Shown are images of cornified envelopes after ultrasound trea
indicated genotypes. Shown are means and standard errors from pooled epidermal
comparing WTand Get 1−/− epidermis. PL, phospholipids; GSL, glucosylceramides;
hydroxyacids; Asl, ceramide containing sphingosine and long α-hydroxyacids; N
containing sphingosine and normal fatty acids; EOS, acylceramide consisting of omeg
the omega-hydroxyl group; CH, cholesterol; FA, fatty acid; SE, cholesterol ester.Electrophoretic mobility shift assay (EMSA)
Sequences extracted by BEARR were used as unlabeled competitor
oligonucleotides in the competition EMSA (Supplementary Table 2). Get-1
protein (0.2 ng/ml) was incubated with [γ32]P-labeled duplex Get-1 consensus
sequence (TCCTGTTAAACCGGTTTTTCTAGT) and EMSA performed as
previously described (Kudryavtseva et al., 2003). The DNA-protein complexes
in the various bands were quantified by cutting them out and measuring their
counts using a scintillation counter. Data were expressed as percent binding
relative to that determined in the absence of a competitor. A competitive
binding curve was used to approximate the concentration of the unlabelled
oligonucleotides (IC50) required for 50% inhibition of binding. The computed
relative affinity is the IC50 of the gene relative to the IC50 of Tgm1.
Co-immunoprecipitations and Western blots
Expression plasmids, pCS2-MT-LMO4 and pCDNA-HA-Get-1 were
transiently transfected into HEK293T cells and cell extracts prepared as
previously described (Lu et al., 2006). Cell extracts were precipitated with an
HA antibody (Covance; MMS-101R) and Western blots were performed with
MT antibody (Upstate; 06-340). Input extracts were analyzed by Western blots
with the same antibodies.
Results
Get-1 regulates terminal differentiation of the epidermis and
the forestomach epithelium
To test whether Get-1 and LMO4 play roles in epidermal
development, we studied mice deleted for Get-1 and LMO4. We
first generated Get-1−/− mice lacking exons 4 to 7, which
encode for the activation domain and part of the DNA-bindingposition in Get-1−/− mice. (A) Epidermal permeability barrier assay by X-gal
lity analysis of cornified envelopes isolated from the epidermis of e18.5 mice of
tment for 0, 15, 30 and 60 s. (C) Lipid composition of epidermis of mice with the
samples in four different experiments. * and ** denote P<0.01 and P<0.002,
GLA, acylglucosylceramide; ASs, ceramide containing sphingosine and short α-
P, ceramide containing sphingosine and short α-hydroxyacids; NS, ceramide
a-hydroxyacids amide-linked to sphingosine and bearing linoleate ester-linked to
127Z. Yu et al. / Developmental Biology 299 (2006) 122–136domain (Figs. 1A–B). The Get-1−/− mice died at birth with
neural tube closure defects characterized by spina bifida (100%)
and exencephaly (14%), and exhibited tail abnormalities
(100%), primarily curly tail (Figs. 1C–E and Supplementary
Table 3). These phenotypes are similar to those previously
described in mice deleted for part of exon 2 and exon 3 of the
Get-1 gene (Ting et al., 2003a). However, in the present
study, the incidence of exencephaly was 7 times higher and
additional abnormalities were observed, including an open-eye
phenotype (7%; Supplementary Table 3) and shorter intestine
with blood in the lumen (Fig. 1F). The mean intestine lengths of
WT and Get 1−/− mice were 6.8 and 5.9 cm, respectively
(P<0.002). The eye and gut phenotypes expand the known
functions of Get-1.
To understand the role of Get-1 in epidermal develop-
ment, we examined skin histology and marker expression inFig. 4. Ultrastructure of Get-1−/− epidermis. (A–B) Stratum corneum of WT (A) and
(D) stratum corneum. Arrowheads indicate intercellular spaces. (E–F) Granular layer
separated cell–cell adhesions in Get-1−/− the epidermis. (G–H) Higher magnificat
desmosomes. Asterisks indicate the abnormally separated intercellular spaces. (I–L)
from WT (I–K) and Get-1−/− (J–L) embryos. CE, cornified envelope; SC, stratum cGet-1−/− mice from embryonic days (e) 14.5 to 18.5 (Figs.
2A–O and Supplementary Fig. 1). At e14.5, the skin
histology was normal but by e16.5 there was thickening of
the epidermis, which became more pronounced at e18.5
(Figs. 2A–C and Supplementary Fig. 1). At this stage, the
cornified layer was more compact and often contained nuclei
(Fig. 2C). The granular layer was thicker due to an increased
number of cell layers and the cells of the most superficial layers
being more cuboidal than normal. The spinous layer was also
thicker and the basal layer appeared disorganized. Keratin 5 and
10 expression appeared normal whereas keratin 6 expression,
often associated with increased epidermal proliferation, was
strongly upregulated in Get-1−/− epidermis, especially close to
the spina bifida (Figs. 2D–I). Examination of the terminal
differentiation markers involucrin, loricrin and filaggrin
revealed that the onset of loricrin expression was delayed atGet-1−/− (B) mice at e18.5. (C–D) Higher magnification of WT (C) and Get-1−/−
of WT (E) and Get-1−/− (F) epidermis from e18.5 embryos. Arrowheads indicate
ion of the granular layer of WT (G) and Get-1−/− (H) mice. Arrows indicate
Lamellar bodies indicated with arrows in the granular layer of e18.5 epidermis
orneum; SG, granular layer.
Fig. 5. Expression pattern of occludin and claudin 1 in WT and Get 1−/− epidermis. (A) Immunofluorescence analysis of occludin expression in WT epidermis. (B)
DAPI staining showing nuclei in the same section as panel A. (C) The merged image of panels A and B. (D) Immunofluorescence analysis of occludin expression in
Get 1−/− epidermis. (E) DAPI staining showing nuclei in the same section as panel D. (F) The merged picture of panels D and E. (G–H) Immunohistochemistry
analysis of claudin 1 expression in WT (G) and Get 1−/− (H) epidermis. SC, cornified layer; SG, granular layer. A nucleus in cornified layer is indicated by arrow. (I)
Western blot analysis of occludin and claudin 1 in WT and Get 1−/− epidermis. Ocln, occludin; Cldn1, claudin 1. Scale bars: panels A–F, 25 μm; G–H, 50 μm.
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were expressed at the appropriate time (Supplementary Fig. 1).
However, all three markers showed an expanded domain of
expression at e18.5, corresponding to expansion of the granular
layer (Figs. 2J–O). Involucrin expression was decreased
slightly at e16.5 (Supplementary Fig. 1) and clearly at e18.5
(Figs. 2J–K). Together, these abnormalities demonstrate
altered terminal differentiation of the Get-1−/− epidermis.
Consistent with epidermal hyperplasia, there was a mild, yet
statistically significant increase in keratinocyte proliferation in
the basal cell layer of the Get-1−/− epidermis (Figs. 2P–Q).
The forestomach epithelium, which is similar to the epidermis,
showed reduced number of granules in the superficial layers
(Figs. 2S–T) and decreased expression of filaggrin and loricrin
(Figs. 2U–V), signifying impaired terminal differentiation of
the forestomach epithelium. These experiments demonstrateFig. 6. Deletion of the Get-1 gene affects the expression of multiple genes crucial
microarray data processing and Cyber-T analysis to identify statistically significan
differentially expressed genes grouped into functional categories important in epith
expression as determined by Cyber-T analysis; bold P values are highly significant (P
exons ofGet-1−/−mice. (C) Semiquantitative RT-PCR of a random selection of genes
is outside the deleted exons of Get-1−/− mice. Gapdh and 18S are endogenous con
complex (EDC). For graphical clarity, only genes that are differentially expressed wit
lines, boundaries of the EDC.that Get-1 plays important roles in the differentiation of
stratified epithelia of both ectodermal and endodermal origin,
thus expanding the role for this mammalian homologue of
Drosophila Grainyhead.
Get-1 regulates the lipid composition, cell–cell adhesion and
barrier function of the epidermis
One key role of the epidermis is the formation of an effective
permeability barrier. By performing an in situ permeability assay
(Hardman et al., 1998), impaired barrier formation was evident
in Get-1−/− mice at e16.5 and e18.5 (Fig. 3A). An effective
barrier depends in part on the structural integrity of the cornified
envelope. To test the fragility of cornified envelopes, we
exposed them to ultrasound for different time periods. Interest-
ingly, the cornified envelope appeared normal or slightly lessfor terminal differentiation and barrier function of epidermis. (A) Overview of
t differentially expressed genes in the backskin of Get-1−/− mice. (B) List of
elial barrier formation. P value corresponds to the significance of differential
<0.0025). Asterisk, the probe set corresponding to Get-1 is outside the deleted
from panel B. Asterisk, the primer set used to interrogate the expression of Get-1,
trols. (D) Fold changes of gene expression within the epidermal differentiation
h P<0.05 are shown with gene symbol, strand direction and fold change. Dotted
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dysfunction is not caused by increased fragility of the cornified
envelope. However, we found that the lipid composition of theepidermis was altered with statistically significantly increased
phospholipids (PL) and decreased fatty acids (FA), which are
implicated in maintaining normal barrier function (Elias, 2005)
(Fig. 3C). Because FA are derived from PL, these findings
indicate an impairment in the conversion of PL to FA (Fluhr
et al., 2001).
To investigate in more detail the epidermal structure of
Get-1−/− mice, we performed transmission electron micro-
scopy (TEM). These experiments showed that the stratum
corneum of the Get-1−/− mice was more compact and that the
corneocytes were enlarged with irregular surface structure
(Figs. 4A–B). The space between the corneocytes, where lipid
lamellar layer normally exists, contained residual material not
found in wild type (WT) mice (Figs. 4C–D), consistent with
abnormalities in lipid composition. Interestingly, intercellular
junctions in the top of the granular layer showed abnormal
separation of cells between desmosomal regions, creating the
appearance of periodic intercellular spaces (Figs. 4E–H). This
adhesion abnormality was observed in three out of five
knockout mice and not in four WT mice. The lipids
synthesized in the cells of the granular layer are packaged
into lamellar bodies that are subsequently secreted for use in
the intercellular spaces of the stratum corneum. Consistent
with abnormal lipid composition, we found that lamellar
bodies are decreased in size and optical density in Get-1−/−
mice (Figs. 4I–L).
Because tight junctions have been shown to be critical for
effective epidermal barrier function, we analyzed the epidermal
expression of claudin 1, claudin 4 and occludin. As expected,
occludin is most highly expressed at the cell surface of
keratinocytes in the granular layer of WT mice (Figs. 5A–C).
Intriguingly, occludin expression appears displaced from the
granular layer but is found aberrantly in the cornified layer of
Get-1−/− mice (Figs. 5D–F). In contrast, although the pattern
of claudin 1 expression appears normal, overall expression
appears slightly decreased in the Get 1−/− epidermis (Figs.
5G–H). Western blot analysis showed that whereas the skin
expression of occludin is increased, claudin 1 protein
expression is decreased in the Get 1−/− mice (Fig. 5I). In
summary, there are abnormalities in the pattern of expression
for occludin and altered expression levels for claudin 1.
Together, these findings are indicative of multiple causes for
the barrier defect of Get-1−/− mice, including changes in
extracellular lipids and defective cell–cell adhesions in the
granular layer.Fig. 7. Identification of evolutionarily conserved Get-1 binding site in promoter
regions of Get-1-regulated genes. (A) Overview of Get-1 binding site analysis in
promoters from differentially expressed genes in Get-1−/− epidermis. As a
control, we also determined the frequency of Get-1 binding sites in non-
regulated genes. (B) Get-1 binding sites in regulated genes. Location of the
binding site in relation to the start site is indicated for both human and mouse
genes. (C) Electrophoretic mobility shift assays with a 32P-labeled consensus
DNA-binding site for the Get-1 protein. Binding was competed with the
indicated amounts of unlabeled binding sites from the indicated Get-1-
responsive genes. Shown on the right are the probability weight matrix
(PWM) scores of potential Get-1 binding sequences as previously determined,
and the affinity of each sequence relative to the site found in the Tgm1 gene.
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involved in lipid metabolism, cell–cell adhesion and structural
integrity of the cornified envelope
To gain insights into the molecular mechanisms of
permeability barrier defects in Get1−/− mice, we performed
expression profiling of backskin RNA from Get1−/− and
WT mice at e18.5 (Fig. 6A). Using the Cyber-T program
(Long et al., 2001) with P<0.0025 (false discovery rate
<20%), we found that only 294 of the 25,064 expressed
probe sets were significantly altered, indicating that deletion
of Get-1 leads to highly selective changes in gene
expression. Of the altered probe sets, 206 (162 unique
genes) were downregulated, and 88 (69 unique genes) were
upregulated (Fig. 6A). A complete list of these genes with
corresponding P-values is provided in Supplementary Table
4. Strikingly, the great majority of differentially expressed
genes play key roles in the terminal differentiation program
and barrier formation, including structural proteins of theFig. 8. Get-1 and LMO4 interact functionally to regulate terminal differentiation of th
the developing epidermis at e15. (B) Co-immunoprecipitation of LMO4 and Get-1. E
transfected into HEK293T cells either alone or together as indicated on top. The top p
HA antibody. The middle and lower panels show the input detected with MTand HA a
LMO4 and Get-1 is indicated with arrows. (C) Phenotypes of WT, Get-1−/−, LMO4
backskin from WT (D), LMO4−/− (E) and LMO4−/−Get-1−/− (F) mice. Scale bar: 25cornified envelope, cell adhesion molecules and enzymes
involved in lipid metabolism (Fig. 6B). A selection of
altered genes from different functional groups was validated
with semi-quantitative RT-PCR (Fig. 6C).
Systematic statistical analysis of chromosomal location
revealed that the significantly downregulated genes were
overrepresented in two adjacent chromosomal bands, 3F1
(P=0.00038) and 3F2.1 (P=0.031). These genes on chromo-
some 3 fall within the epidermal differentiation complex (EDC),
which comprises a large number of genes that encode structural
proteins of the cornified envelope (Fig. 6D). Although Get-1
regulates the majority of the genes within the EDC, it is of note
that some genes are downregulated whereas others are
upregulated. This is in contrast to the Klf4 transcription factor,
which represses all Sprr2 and Sprr1 genes (Segre et al., 1999),
indicating that these two regulatory factors act differently on the
EDC. In addition, there is a decrease in the expression of a large
number of adhesion molecules, including claudins, occludin,
Plakophilin 3 and Periplakin (Fig. 6B) which likely contributese epidermis. (A) In situ hybridization showing expression of LMO4 and Get-1 in
xpression vectors encoding Myc tagged (MT) LMO4 and HA-tagged Get-1 were
anel shows a Western blot with MT antibody after immunoprecipitation with an
ntibodies, respectively. Prominent bands in the top panel are IgG. The location of
−/− and LMO4−/−Get-1−/− e18.5 embryos. (D–F) Histological analysis of e18.5
μm. SB, basal layer; SC, cornified layer; SG, granular layer; SS, spinous layer.
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Get-1−/− mice.
Extracellular lipids such as free fatty acids, ceramide,
cholesterol and cholesterol esters form a lamellar lipid layer
between corneocytes and are essential for the barrier function of
the epidermis. Several enzymes, including phospholipase A2,
acid sphingomyelinase and beta-glucocerebrosidase are
involved in the modification of these lipids (Elias, 2005).
Among all significantly downregulated genes, we found that the
most overrepresented gene ontology biological process cate-
gory is lipid metabolism (P=0.000014), including enzymes and
transporters for lipid metabolism (Fig. 6B); nearly all theseFig. 9. Impaired stratum corneum formation in LMO4−/−Get-1−/− epidermis. (A–C)
and LMO4−/−Get-1−/− epidermis (C). (D) Immunostaining analysis of e18.5 epidermis
left hand. Scale bar: 50 μm. CE, cornified envelope.genes were markedly downregulated. These include several A2
phospholipases that are critical for conversion of PL to FA
(Fluhr et al., 2001), which is defective in theGet-1−/− mice (Fig.
3C). In addition, several of the downregulated enzymes,
including Aloxe3, Alox12b (Jobard et al., 2002) and DGAT2
(Stone et al., 2004), have been shown in gene knockouts to be
required for normal barrier function. Taken together, our results
suggest that the cause of the defective barrier of Get-1−/− mice
is multifactorial, involving structural components, cell–cell
adhesion and lipid metabolism.
To discover potential Get-1 binding sites in differentially
expressed genes, we extracted 2 kb sequences upstream of theCornified envelopes isolated from e18.5 epidermis from WT (A), LMO4−/− (B)
from embryos of the indicated genotypes. The antibodies used are shown on the
133Z. Yu et al. / Developmental Biology 299 (2006) 122–136transcription start site of these genes and performed positional
weight matrix (PWM) analysis (Fig. 7A). Because Tgm1 is the
only known putative target gene of Get-1, we used the PWM
score of the potential Get-1 binding site in the upstream region
of Tgm1 (6.73) as the cut-off. Using the ConSite program
(Sandelin et al., 2004), we determined the mouse–human
conservation of the potential binding site as well as the
surrounding genomic region. We thus found seven down-
regulated genes and three upregulated genes with highly
conserved sites, most of them linked to terminal differentiation
of keratinocytes (Eckert et al., 2004; Higashi et al., 2004; Koch
et al., 2000; Marenholz et al., 2001; Xie et al., 1993). No
conserved sites were found in the non-regulated genes,
indicating that the presence of high affinity Get-1 binding
sites in these genes cannot be explained by chance alone (Fig.
7A). The conserved sites are all found within highly conserved
genomic regions suggesting that they are part of gene-
regulatory modules (Fig. 7B). Whereas this analysis suggests
that some of the differentially expressed genes in the Get-1−/−
epidermis could be direct target genes, further experiments with
in vivo Get-1 binding and mutagenesis in transgenic mice are
required for identification of direct target genes. We tested a
random selection of potential Get-1 binding sites, some of
which are in the conserved regions, and found a good
correlation between binding affinity of the sites and their
PWM score, thus validating previously described consensus
sequence (Ting et al., 2005) (Fig. 7C). Interestingly, both up-
and down-regulated genes contain conserved high-affinity
binding sites, suggesting that Get-1 can act as an activator
and repressor on distinct target genes (Kudryavtseva et al.,
2003).
Get-1 interacts functionally with LMO4 to regulate terminal
differentiation of the epidermis
We reported that Get-1 and LMO4 interact in vitro and have
overlapping expression patterns during epidermal development
(Fig. 8A) (Kudryavtseva et al., 2003). Consistent with previous
results of GST pulldown assays and yeast two-hybrid interac-
tions assays, Get-1 and LMO4 co-immunoprecipitate when
transfected into HEK293T cells (Fig. 8B). However, the
epidermal phenotype of LMO4−/− mice has not been character-
ized, and it is not known whether there are genetic interactions
between LMO4 and Get-1 during development, including
epidermal differentiation. Similar to Get-1−/− mice, LMO4−/−
mice die at birth and exhibit abnormal neural tube closure,
although more frequently at the anterior end (Lee et al., 2005)
(Fig. 8C). In contrast to Get-1−/− mice, the epidermal barrier
forms normally in LMO4−/− mice (Supplementary Fig. 2). To
test the hypothesis that there are genetic interactions between
Get-1 and LMO4, we crossbred LMO4+/− and Get-1+/− mice to
generate double knockout mice. Get1/LMO4 double knockout
mice show significantly more frequent exencephaly (100%) than
that found in single knockouts (14% for Get-1−/− and 55% for
LMO4−/−). Similarly, open-eye phenotype was more penetrant
in double knockout mice (Get-1−/−, 7%; LMO4−/−, 16%; and
Get-1−/−LMO4−/−, 54%), consistent with a genetic interactionbetween these two genes (Fig. 8C and Supplementary Table 3).
To study epidermal differentiation, we isolated backskin from
e18.5 mice representing the four genotypes: WT, Get1−/−,
LMO4−/− and Get1−/−LMO4−/−. Whereas LMO4 knockout skin
did not exhibit clear morphological abnormalities, compared to
Get-1−/− mice, skin from double knockout mice showed marked
impairment of stratum corneum formation with most cells in the
top of the epidermis containing nuclei (Figs. 8D–F). Many cells
showed enlarged vacuolar-like structure not normally found in
the granular layer of the epidermis. This abnormality was
primarily found at the anterior part of the embryo in the skin
covering the head and upper body regions.
To further demonstrate the failure of epidermal terminal
differentiation, we isolated cornified envelopes from WT,
LMO4−/− and Get1−/−LMO4−/− mice and found that although
LMO4−/− cornified envelopes are normal, they were essentially
absent in the double knockout mice (Figs. 9A–C). These
findings indicate a severe abnormality in cornified layer
formation, consistent with the expression of epidermal protein
markers K5, K10, filaggrin, loricrin and involucrin, which are
not normally detected in the cornified layer (Fig. 9D). The
enhancement of the terminal differentiation defect in the double
knockouts indicates that Get-1 and LMO4 interact functionally
to regulate this process.
Discussion
Expression of the Get-1 gene is initiated in the somatic
ectoderm prior to formation of epidermis and continues in the
proliferating cells of the developing epidermis (Fig. 8A). By
birth, however, the expression level has decreased and
transcripts are limited to the suprabasal compartment of the
epidermis (Kudryavtseva et al., 2003). In light of the early
expression ofGet-1, it is interesting that the gene is critical for the
terminal differentiation of keratinocytes later in embryogenesis.
These results suggest that the terminal differentiation program of
epidermis is initiated relatively early during skin development.
In addition to epidermis, the Get-1 gene is expressed in
endoderm-derived epithelia such as that of the gut, the
respiratory track and the genitourinary system (Kudryavtseva
et al., 2003). Consistent with these data, we now show that the
function of Get-1 is not limited to ectodermal epithelia. The
forestomach epithelium,which is highly similar to the epidermis,
exhibits impaired terminal differentiation with a striking
decrease in the expression of the terminal differentiation markers
loricrin and filaggrin (Figs. 2S–V).
Increased epidermal thickness with expansion of all
epidermal layers, especially the granular layer, is a prominent
feature of the Get-1−/− phenotype. Increased proliferation of
basal cell layer keratinocytes (Figs. 2P and Q) accounts for part
of the epidermal thickening, but impaired cell death in the top of
the granular layer may also contribute to this abnormality. Thus,
we noticed frequent persistence of nuclei in the stratum
corneum (Fig. 2C) and decreased caspase 14 expression in the
granular layer of Get-1−/− mice (data not shown). The increased
epidermal proliferation is not likely a cell-autonomous effect of
Get-1 because proliferation is upregulated in the basal cell layer
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compartment.
In addition to hyperplasia, the main epidermal abnormalities
in Get-1−/− mice are found in the cornified and granular layers.
Keratinocytes in the granular layer show defective flattening
(Figs. 2B–C) and abnormal cell–cell adhesion (Figs. 4E–H).
The cornified layer shows striking abnormalities with increased
thickness, tighter cell–cell adhesion and frequent persistence of
nuclei (Figs. 2C and 3B). The persistence of nuclei in the
stratum corneum indicates impairment of enucleation at the top
of the granular layer, an important component of the terminal
differentiation program. From a functional standpoint these
morphological abnormalities are significant because the barrier
function of Get-1−/− mice is severely impaired (Fig. 3A).
We performed gene expression profiling to gain insights into
the molecular mechanisms underlying the morphological and
functional defects in the Get-1−/− epidermis (Fig. 6). The results
suggest that alterations in the expression of multiple genes
encoding key functional components of the terminal differ-
entiation program contribute to defective epidermal barrier. In
particular, our findings indicate that lipid abnormalities may
cause defective barrier function of Get-1−/− mice. We found
increased PL and decreased FA (Fig. 3C), which is implicated in
maintaining normal barrier function (Elias, 2005). This finding
is consistent with decreased expression of several A2
phospholipases (Fluhr et al., 2001) (Fig. 6B) that are critical
for conversion of PL to FA (Fluhr et al., 2001). Altered
appearance of lamellar bodies (Figs. 4I–L), as well as defective
lipid lamellar formation in the cornified layer (Figs. 4C–D),
also support an important role for Get-1 in regulation of
epidermal lipids.
In addition to regulating lipids we found that Get-1 plays an
important role in regulating transcripts involved in cell–cell
adhesion, a key feature of an effective epidermal barrier. In the
granular layer, there are three different cell junctions–
desmosomes, tight junctions and adherence junctions–respon-
sible for “sealing” the membranes of adjacent cells and
maintaining barrier function. Knockouts of tight junction
proteins (Furuse et al., 2002) and desmosomal proteins
(Chidgey et al., 2001) lead to barrier defects. Therefore, the
decrease in the expression of a large number of tight junction
molecules, including several claudins and occludin (Figs. 6B–
C), may contribute to the adhesion (Figs. 4G–H) and barrier
(Fig. 3A) defects of Get-1−/− mice. Most strikingly, we found
that the distribution of occludin is altered with decreased
expression in the granular layer and aberrant expression in the
cornified layer of Get-1−/− mice (Figs. 5D–F). Desmosomal
defects could also be involved because a similar cell–cell
adhesion abnormality was found in the granular layer of mice
ectopically expressing Desmoglein 3 in the suprabasal
compartment (Merritt et al., 2002). Consistent with this notion,
Plakophilin 3 and Periplakin (Figs. 6B–C) were significantly
downregulated in Get-1−/− epidermis.
Get-1 is also critical for normal expression of many structural
components of the cornified envelope such as involucrin,
Sprr1a, Sprrl10 and S100a3. Yet, the strength of the cornified
envelope of Get-1−/− mice appeared normal (Fig. 3B). Onepossible explanation for this apparent dichotomy is that several
structural components, including Sprr2d, Sprr2h and Repetin,
were upregulated, thus compensating for the decreased expres-
sion of other components as has been suggested in loricrin
knockout mice (Koch et al., 2000).
Taken together, our results strongly suggest that Get-1 plays
a broad role in terminal differentiation of the epidermis and that
the defective epidermal barrier of Get-1−/− mice is due to
alterations in the expression of multiple genes. Consistent with
this idea, the epidermal phenotype of Get-1−/− mice is striking
whereas the magnitude of change for most genes in Get-1−/−
epidermis is quite modest. The abnormal permeability barrier of
Get-1−/− mice was previously proposed to result from decreased
Tgm1 expression without the involvement of other factors
involved in barrier formation (Ting et al., 2005). Our findings
directly contradict these conclusions, and for several reasons we
think that downregulation of Tgm1 is unlikely to fully explain
the epidermal phenotype of Get-1−/− mice. First, although the
barrier defect is striking, the downregulation of Tgm1 is modest,
approximately two-fold. Second, although Tgm1−/− mice
exhibit dramatic defects in CE formation and strength
(Kuramoto et al., 2002), the fragility of the CE is decreased if
anything in Get-1−/− mice (Fig. 3B), perhaps due to functional
overcompensation of cornified envelope proteins such as
Repetin, and certain S100 and Sprr proteins. Third, we have
demonstrated altered expression of transcripts for many other
key molecules involved in terminal differentiation of the
epidermis and barrier formation.
To begin understanding the transcriptional mechanisms
underlying gene expression changes in Get-1−/− epidermis, we
have studied the frequency of Get-1 binding sites in the
regulatory regions of differentially expressed genes (Fig. 7A).
Although the data does not allow us to determine which of these
genes are direct targets of Get-1, we have obtained clear
statistical evidence that Get-1 binding sites are enriched in Get-
1-responsive genes. Interestingly, however, Get-1-binding sites
are absent in the conserved regions of the 2-kb of 5′ flanking
sequence for most genes altered in Get-1−/− epidermis. These
genes may well contain Get-1 binding sites at a greater distance
from the start site. For example, a locus control region at a
distance may regulate the EDC locus (Martin et al., 2004), which
contains many Get-1-responsive genes (Fig. 6D). Heretofore,
Klf4 is the only transcription factor conclusively shown to
regulate multiple genes of the EDC (Patel et al., 2003; Segre et
al., 1999). However, Get-1 appears to act differently than Klf4
because in the Get-1−/− mice some of the EDC genes are
upregulated while others are downregulated. Some transcripts
may also be altered in response to the barrier defect, injury and
epidermal hyperplasia of Get-1−/− mice. These include Sprr2
family members, also upregulated in the loricrin knockout mice
(Koch et al., 2000), as well as S100A8 and S100A9, which are
downstream of AP1 (Figs. 6B and C) (Zenz et al., 2005).
Interestingly, both S100A9 and Repetin transcript levels were
increased at least as early as e16.5 (Supplementary Fig. 3). Based
on the expression analysis, it is unlikely that alteration in the
expression of other transcription factors mediate all actions of
Get-1. Expression of Klf4 is not significantly decreased in the
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1, a POU domain factor involved in epidermal differentiation, is
unlikely to be a major contributor because singular deletion of
the Skn-1 gene causes a very mild abnormality in the terminal
differentiation of the epidermis (Andersen et al., 1997).
Because we cloned Get-1 as an LMO4-interacting protein
(Kudryavtseva et al., 2003), it was of interest to determine
whether there are interactions between the two genes in
epidermal development. Gene knockouts for both LMO4
(Hahm et al., 2004; Lee et al., 2005; Tse et al., 2004) and
Get-1 (Ting et al., 2003a) result in neural tube defects,
which support the possibility that interaction between the two
proteins is important. Interestingly, however, the epidermis of
LMO4−/− mice appears normal (Figs. 8D–E; Supplementary
Fig. 2), indicating that under non-perturbed conditions, Get-1
can function without LMO4. Yet, deletion of the Get-1 gene
in the absence of the LMO4 gene leads to a much more
striking phenotype with a dramatic impairment in the
formation of the cornified layer, and a markedly abnormal
granular layer (Figs. 8F and 9). Furthermore, the penetrance
of the eye-open and exencephaly phenotypes is significantly
increased in the double knockouts compared to either single
knockout (Supplementary Table 3). Together, these findings
demonstrate genetic interactions between LMO4 and Get-1
and based on the ability of these proteins to interact in vitro,
it is tempting to speculate that the functional interaction
results from altered transcriptional complexes in which both
LMO4 and Get-1 participate. It is also possible that LMO4
and Get-1 play sequential roles at different stages in the
control of epidermal development.
In conclusion, our results suggest that Get-1 plays an
important role in the terminal differentiation and barrier
function of the epidermis by regulating multiple genes,
including those of the EDC complex encoding structural
proteins, enzymes controlling extracellular lipid metabolism,
cell adhesion molecules and protein-modifying enzymes.
Furthermore, Get-1 interacts functionally with LMO4 to
regulate terminal differentiation of the epidermis. The broad
range of genes whose expression is altered by Get-1 deletion
implicates Get-1 proximally in a complex pathway that
ultimately coordinates different aspects of the terminal
differentiation program in epidermis.
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